ArticleJPGN reports2026
Collagenous gastritis: A cause of anemia and gastric nodularity in the pediatric population.
Article in JPGN reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Collagenous gastritis: A cause of anemia and gastric nodularity in the pediatric population.JPGN reports · 2026Article
- Case Report: Steroid-responsive recurrent iron-deficiency anemia in pediatric collagenous gastritis.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present a case series of seven pediatric patients with collagenous gastritis (CG) with the aim of contributing data to existing literature about this rare disease to assist in the understanding and management of these patients. Gross nodularity seen on esophagogastroduodenoscopy and increased subepithelial collagen on biopsy were noted in the gastric body of all seven patients. Iron deficiency anemia was also diagnosed in all patients and did improve with iron supplementation. The most common symptoms were abdominal pain, fatigue, dizziness, and vomiting. Some patients seemed to have improvements in abdominal pain after use of antisecretory agents, such as proton pump inhibitors and histamine (H2) antagonists. All of the patients in our study had complete resolution of symptoms, but none showed improvements histologically. Even three patients who were trialed on oral or topical budesonide exhibited neither gross nor histologic improvements. Further clinical trials are needed to identify effective therapeutic strategies for CG that can result in long-term histological improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.